glp-1 pregnancy category Receptor Agonists, Fertility Restoration, and Reproductive Safety in Women of Reproductive Age: A Narrative Review Glucagon-like peptide-1 receptor agonist use

The medication has quickly grown in popularity due to the clinical trials that have shown it to reliably offer better results than the rest of the weight loss medications that are currently available on the market

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

The drug was originally approved by the FDA in 1979 as an antihypertensive (brand name Loniten) at doses of 10 to 40 mg daily [1]

The peptide has a short half-life of less than 30 minutes and is rapidly metabolized, which means consistent dosing protocols matter significantly

Not the forum anecdotes or the marketing claims, but the peer-reviewed mechanisms and outcomes

Some people take it once daily, while others split it into two servings (for example, one in the morning and one later in the day)